Sugi Predict

Sugi Predict / Compounds / SCHEMBL1974989

SCHEMBL1974989

SCHEMBL1974989

CCCNn1c(C)c(C(=O)N[C@H](c2cccc(F)c2)C2CCC2)c(C)c(Cl)c1=O

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CYP2C9 P11712 2/20 0.45
▸ TACR3 P29371 10/20 0.41
▸ OPRL1 P41146 1/20 0.35
▸ PPARG P37231 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ GRM5 P41594 3/20 0.34
▸ FAAH O00519 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1974172 0.90 CYP2C9 (0.45) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL1976633 0.88 CYP2C9 (0.43) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL1973908 0.86 CYP2C9 (0.48) CYP2C9TACR3PPARGRIPK1
SCHEMBL1977657 0.85 CYP2C9 (0.45) CYP2C9TACR3OPRL1MEN1ALDH1A1
SCHEMBL11917792 0.85 CYP2C9 (0.46) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL11917795 0.85 CYP2C9 (0.46) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL11917788 0.85 CYP2C9 (0.46) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL7950413 0.85 CYP2C9 (0.46) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL7942351 0.84 CYP2C9 (0.44) CYP2C9TACR3OPRL1PPARGMEN1
SCHEMBL2371286 0.83 CYP2C9 (0.44) CYP2C9TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011072691-A1 PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2011-06-23 — — WO claimed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 — — US claimed
US-8207347-B2 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-06-26 — — US disclosed
US-8207347-B2 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2012-06-26 — — US disclosed
WO-2011072691-A1 PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2011-06-23 — — WO disclosed
WO-2011072691-A1 PYRIDONE DERIVATIVES AS NK3 ANTAGONISTS H. LUNDBECK A/S (DK) 2011-06-23 — — WO disclosed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 — — US disclosed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 — — US disclosed
US-20110144164-A1 Pyridone derivatives as NK3 antagonists H. LUNDBECK A/S (DK) 2011-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144164-A1 Pyridone derivatives as NK3 antagonists KCNK3, GRIK3, KCND3 CYP2C9 2501/4885TACR3 26/4885OPRL1 821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.